DEPLOYDatabase

Deployment

ReWalk 7 at United States

Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025. Motor-driven powered gait for spinal-cord-injury users.

ReWalk 7 by Lifeward · Operated by Lifeward · Catalog entry · 2 sources · not yet field-verified · Exoskeletons

Track ReWalk 7 at United States

Recent coverage

See all coverage →

Machine-readable surfaces

Footage

PRIMARY SOURCE
Courtesy of Lifeward

Lifeward's footage of a user navigating stairs and curbs in the current-generation ReWalk personal exoskeleton (ReWalk 7). Stepping is triggered by tilt sensors and the user's forward body-weight shift, with crutches for balance: worn and user-controlled, not autonomous.

ReWalk 7 (FDA cleared March 2025) is the latest generation personal exoskeleton for spinal-cord-injury users. Major reimbursement milestones in 2025-2026: UnitedHealthcare (Nov 2025), Humana (Dec 2025), and Aetna (Feb 2026) Medicare Advantage prior authorizations cover ~16M beneficiaries. CMS 2024 Home Health PPS Rule created lump-sum reimbursement pathway. June 2025 ALJ ruling established precedent that personal exoskeletons are 'reasonable and necessary.' Only FDA-cleared personal exoskeleton with stairs/curbs capability. Home use and clinical deployment across the US.

Key facts

FDA clearance
ReWalk 7 cleared March 2025
Medicare Advantage coverage
Aetna (Feb 2026), Humana (Dec 2025), UnitedHealthcare (Nov 2025) — ~16M beneficiaries total
CMS pathway
2024 Medicare Home Health PPS Rule placed personal exoskeletons in brace benefit category, effective Jan 1 2024
ALJ precedent
June 2025: Administrative Law Judge ruled ReWalk 'reasonable and necessary' for Medicare beneficiary
Capability
Only personal exoskeleton cleared for stairs and curbs

Safety record

No incidents on record for ReWalk 7 at United States.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Catalog entry · 2 sources · not yet field-verifiedhow tiers work →
Last updated
2026-07-22
Model
ReWalk 7
Company
Lifeward
Location
United States
Operator
Lifeward
Status
operational
Operator type
maker operated
ID
766748ba-e7ce-4860-9603-2b77dde9e286

Timeline

  1. Jun 2026
    created
  2. Jul 2026
    Current status: operational, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

ReWalk 7 operates in United States. Explore the full verified map:

Sources (2)

  1. https://ir.golifeward.com/news-releases/news-release-details/fda-issues-clearance-rewalk-7-exoskeleton
  2. https://golifeward.com/blog/lifewards-rewalk-personal-exoskeleton-now-covered-by-aetna-coverage-expands-to-include-three-of-the-largest-medicare-advantage-insurers/
Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-07-22

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-07-22

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

1
primary-company-ir
Company IR disclosure
1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for ReWalk 7 at United States.

Common questions

What is the ReWalk 7 deployment at United States?
ReWalk 7, built by Lifeward, is recorded as a deployment at United States on the DEPLOY registry. Lifeward operates the deployment directly.
Who operates ReWalk 7 at United States?
Lifeward, the manufacturer of ReWalk 7, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
Have there been incidents at the ReWalk 7 deployment at United States?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.